Alto Neuroscience, Inc. ANRO
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 319.34M | 243.73M | 263.76M | 176.48M | 137.82M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.85M | 3.59M | 5.36M | 1.23M | 1.63M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 323.20M | 247.32M | 269.13M | 177.72M | 139.45M |
|
|
|||||
| Total Current Assets | 323.20M | 247.32M | 269.13M | 177.72M | 139.45M |
| Net Property, Plant & Equipment | 2.74M | 5.91M | 6.30M | 6.13M | 6.49M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 566.00K | 838.00K | 838.00K | 838.00K | 1.07M |
| Total Assets | 326.51M | 254.07M | 276.26M | 184.69M | 147.01M |
|
|
|||||
| Total Accounts Payable | 3.47M | 4.02M | 3.37M | 1.88M | 2.06M |
| Total Accrued Expenses | 8.48M | 7.50M | 6.31M | 7.71M | 5.87M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.88M | 5.13M | 3.44M | 1.74M | 1.12M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 17.84M | 16.65M | 13.12M | 11.33M | 9.05M |
|
|
|||||
| Total Current Liabilities | 17.84M | 16.65M | 13.12M | 11.33M | 9.05M |
| Long-Term Debt | 11.47M | 14.88M | 16.22M | 18.40M | 22.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 673.00K | 3.28M | 3.56M | 3.82M | 3.97M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 29.98M | 34.82M | 32.89M | 33.55M | 35.45M |
|
|
|||||
| Common Stock & APIC | 577.14M | 474.74M | 471.23M | 352.75M | 297.00M |
| Retained Earnings | -280.63M | -255.51M | -227.87M | -201.63M | -185.45M |
| Treasury Stock & Other | 19.00K | 17.00K | 13.00K | 22.00K | 14.00K |
| Total Common Equity | 296.53M | 219.25M | 243.37M | 151.14M | 111.56M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 296.53M | 219.25M | 243.37M | 151.14M | 111.56M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 296.53M | 219.25M | 243.37M | 151.14M | 111.56M |
|
|
|||||